433 related articles for article (PubMed ID: 10469632)
21. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
22. Non-melanoma skin cancer in mouse and man.
Schwarz M; Münzel PA; Braeuning A
Arch Toxicol; 2013 May; 87(5):783-98. PubMed ID: 23266722
[TBL] [Abstract][Full Text] [Related]
23. Differential gene expression during tumor promotion and progression in the mouse skin model.
Bowden GT; Ostrowski LE; Bonham K; Krieg P
Basic Life Sci; 1991; 57():127-40; discussion 140-1. PubMed ID: 1667569
[No Abstract] [Full Text] [Related]
24. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
Scribner JD; Scribner NK; McKnight B; Mottet NK
Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
Reiners JJ; Singh KP
Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
[TBL] [Abstract][Full Text] [Related]
26. Induction of papillomas with a high probability of conversion to malignancy.
Hennings H; Shores R; Mitchell P; Spangler EF; Yuspa SH
Carcinogenesis; 1985 Nov; 6(11):1607-10. PubMed ID: 2414025
[TBL] [Abstract][Full Text] [Related]
27. Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols.
Katiyar SK; Mohan RR; Agarwal R; Mukhtar H
Carcinogenesis; 1997 Mar; 18(3):497-502. PubMed ID: 9067548
[TBL] [Abstract][Full Text] [Related]
28. Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesis.
Yuspa SH; Kilkenny A; Cheng C; Roop D; Hennings H; Kruszewski F; Lee E; Strickland J; Greenhalgh DA
Environ Health Perspect; 1991 Jun; 93():3-10. PubMed ID: 1773799
[TBL] [Abstract][Full Text] [Related]
29. Regression and progression characteristics of papillomas induced by chrysarobin in SENCAR mice.
Battalora MS; Conti CJ; Aldaz CM; Slaga TJ; Johnston DA; DiGiovanni J
Carcinogenesis; 1996 May; 17(5):955-60. PubMed ID: 8640943
[TBL] [Abstract][Full Text] [Related]
30. Characterization of benzo[a]pyrene-initiated mouse skin papillomas for Ha-ras mutations and protein kinase C levels.
Colapietro AM; Goodell AL; Smart RC
Carcinogenesis; 1993 Nov; 14(11):2289-95. PubMed ID: 8242857
[TBL] [Abstract][Full Text] [Related]
31. Further studies on the influence of initiation dose on papilloma growth and progression during two-stage carcinogenesis in SENCAR mice.
DiGiovanni J; Walker SE; Aldaz CM; Slaga TJ; Conti CJ
Carcinogenesis; 1993 Sep; 14(9):1831-6. PubMed ID: 8403206
[TBL] [Abstract][Full Text] [Related]
32. Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression.
Ostrowski LE; Finch J; Krieg P; Matrisian L; Patskan G; O'Connell JF; Phillips J; Slaga TJ; Breathnach R; Bowden GT
Mol Carcinog; 1988; 1(1):13-9. PubMed ID: 3151258
[TBL] [Abstract][Full Text] [Related]
33. Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice.
Gimenez-Conti IB; Bianchi AB; Fischer SM; Reiners JJ; Conti CJ; Slaga TJ
Cancer Res; 1992 Jun; 52(12):3432-5. PubMed ID: 1375869
[TBL] [Abstract][Full Text] [Related]
34. Oral mucosal carcinogenesis in SENCAR mice.
Kim TW; Chen Q; Shen X; Regezi JA; Ramos DM; Tanaka H; Jordan RC; Kramer RH
Anticancer Res; 2002; 22(5):2733-40. PubMed ID: 12529989
[TBL] [Abstract][Full Text] [Related]
35. Transplantation analyses of the immunogenicity of epidermal tumors generated in murine skin two-stage carcinogenesis protocols.
Reiners JJ; Singh KP; Yoon HL; Conti CJ
Mol Carcinog; 1997 Sep; 20(1):48-57. PubMed ID: 9328435
[TBL] [Abstract][Full Text] [Related]
36. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
[TBL] [Abstract][Full Text] [Related]
37. Decreases in phorbol ester-induced papilloma development in v-Ha-ras transgenic TG.AC mice during reduced gene dosage of bcl-2.
Trempus CS; Haseman JK; Tennant RW
Mol Carcinog; 1997 Sep; 20(1):68-77. PubMed ID: 9328437
[TBL] [Abstract][Full Text] [Related]
38. Two-stage tumor promotion in mouse skin: an alternative interpretation.
Hennings H; Yuspa SH
J Natl Cancer Inst; 1985 Apr; 74(4):735-40. PubMed ID: 3921746
[No Abstract] [Full Text] [Related]
39. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
40. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
